Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients

American Journal of Rhinology and Allergy

Volumn 27, Issue 5, 2013, Pages 381-386

  Oyer, Samuel L ^a   Nagel, Whitney ^a   Mulligan, Jennifer K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE;

ADULT; ARTICLE; CELL SUSPENSION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; PROTEIN EXPRESSION; SINONASAL FIBROBLAST; STIMULATION;

ADOLESCENT; ADULT; AGED; CELL COMMUNICATION; CELLS, CULTURED; CHRONIC DISEASE; CYTOKINES; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; NASAL POLYPS; PARANASAL SINUSES; RHINITIS; SINUSITIS; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84888405681     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3934     Document Type: Article

References (28)

1. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61:1280-1289, 2006.
2. Van Cauwenberge P, Van Hoecke H, and Bachert C. Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep 6:487-494, 2006.
3. Flavell SJ, Hou TZ, Lax S, et al. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 158:241-246, 2008.
4. McGettrick HM, Smith E, Filer A, et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 39:113-125, 2009.
5. Parsonage G, Filer AD, Haworth O, et al. A stromal address code defined by fibroblasts. Trends Immunol 26:150-156, 2005.
6. Demoly P, Sahla M, Campbell AM, et al. ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin Exp Allergy 28:731-738, 1998.
7. Kanai N, Denburg J, Jordana M, and Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 150:1094-1100, 1994.
8. Nonoyama T, Harada T, Shinogi J, et al. Immunohistochemical localization of cytokines and cell adhesion molecules in maxillary sinus mucosa in chronic sinusitis. Auris Nasus Larynx 27:51-58, 2000.
9. Shimomura A, Ikeda K, Suzuki H, et al. Expression of adhesion molecules in nonallergic chronic sinusitis. Laryngoscope 107:1519-1524, 1997.
10. Montefort S, and Holgate ST. Adhesion molecules and their role in inflammation. Respir Med 85:91-99, 1991.
11. Bochner BS, LuscinskasFW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1 activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules. J Exp Med 173:1553-1556, 1991.
12. Yoshifuku K, Matsune S, Ohori J, et al. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 45:235-241, 2007.
13. Lim YC, Wakelin MW, Henault L, et al. Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow. Microcirculation 7:201-214, 2000.
14. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J Allergy Clin Immunol 104:917-926, 1999.
15. Jahnsen FL, Haraldsen G, Aanesen JP, et al. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Resp Cell Mol Biol 12:624-632, 1995.
16. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:1-298, 2012.
17. Mulligan JK, Mulligan RM, Atkinson C, and Schlosser RJ. Human sinonasal epithelial cells direct dendritic function and T-cell T helper 1/T helper 2 skewing following Aspergillus exposure. Int Forum Allergy Rhinol 1:268-274, 2011.
18. Bleier BS, Mulligan RM, and Schlosser RJ. Primary human sinonasal epithelial cell culture model for topical drug delivery in patients with chronic rhinosinusitis with nasal polyposis. J Pharm Pharmacol 64:449-456, 2012.
19. Platt MP, Soler Z, Metson R, and Stankovic KM. Pathways analysis of molecular markers in chronic sinusitis with polyps. Otolaryngol Head Neck Surg 144:802-808, 2011.
20. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 124:478-484, 2009.
21. Hamilos DL, Leung DY, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 15:443-450, 1996.
22. Kramer MF, and Rasp G. Nasal polyposis: eosinophils and interleu-kin-5. Allergy 55:669-680, 1999.
23. Sabatini F, Silvestri M, Sale R, et al. Fibroblast-eosinophil interaction. Modulation of adhesion molecules expression and chemokine release by human fetal lung fibroblasts in response to IL-4 and TNF-alpha. Immunol Lett 84:173-178, 2002.
24. Elmorsy S, El-Naggar MM, Abdel aal SM, et al. Sinus aspirates in chronic rhinosinusitis: Fungal colonization of paranasal sinuses, evaluation of ICAM-1 and IL-8 and studying of immunological effect of long-term macrolide therapy. Rhinology 48:312-317 2010.
25. Suzuki H, and Ikeda K. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment. Curr Drug Targest Inflamm Allergy 1:117-126, 2002.
26. Yoshida N, Muraguchi M, Kamata M, et al. Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblasts. Int Arch Allergy Immunol 150:352-358, 2009.
27. Valera FC, Queiroz R, Scrideli C, et al. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clin Exp Allergy 39:81-88, 2009.
28. Onerci M, Elsurer C, Guzel EE, et al. Distribution of inflammatory cells, adhesion molecules, intermediate filaments, and chemokine receptors in subgroups of nasal polyp patients. Am J Rhinol Allergy 25:e176-e180, 2011. (DOI: 10.2500/ajra. 2011.25.3635.)